Prevention & Control Clinical Trial
Official title:
Substantivity of Mouthrinse Formulations Containing Cetylpyridinium Chloride and O-cymen-5-Ol Compared to Placebo on Salivary Microbiota
A desirable quality of mouthrinses is substantivity an intrinsic feature of some molecules. Substantivity requires the adsorption of the agent on the oral surfaces and subsequently antimicrobial activity bacteriostatic along following hours. This work aims to quantitatively determine the substantivity of (i) a single o-Cymen-5-ol plus CPC oral rinse, (ii) a, CPC oral rinse and (iii) a o-Cymen-5-ol mouthwash on the salivary microbiota up to 4 h after their application.
One of the desirable qualities of mouthrinses is substantivity, which is defined as the persistence capacity of its antimicrobial action over time in the mouth. This is an intrinsic feature of some molecules. Such substantivity seems to require the adsorption of the agent on the buccal surfaces and subsequently exert a certain antimicrobial activity that seems to be mostly bacteriostatic. Substantivity is the result of multiple factors controlling or altering adhesion, life period of antimicrobial capabilities, synergisms, antagonisms, and others. In order to improve substantivity and therefore increase antimicrobial effectiveness of CPC, o-Cymen-5-ol has recently been proposed to become incorporated to oral rinses. The aim of this work is to quantitatively determine the substantivity of (i) a single o-Cymen-5-ol plus CPC oral rinse, (ii) a, CPC oral rinse and (iii) a o-Cymen-5-ol mouthwash on the salivary microbiota up to 4 h after their application. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04062578 -
Effects Provided by a Physiotherapy Treatment Preventing Lower Extremity Injuries in Female Football Players
|
N/A | |
Not yet recruiting |
NCT04400019 -
Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
|
Phase 2/Phase 3 | |
Completed |
NCT00793455 -
Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders
|
N/A | |
Completed |
NCT00563264 -
KAN-DO: A Family-based Intervention to Prevent Childhood Obesity
|
N/A | |
Completed |
NCT05261152 -
S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
|
Phase 4 | |
Completed |
NCT02165709 -
Cohort Study of Risk Reducing Salpingectomy
|
N/A | |
Recruiting |
NCT06164600 -
Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
|
Phase 2 | |
Completed |
NCT01776424 -
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
|
Phase 3 | |
Enrolling by invitation |
NCT02580279 -
Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy
|
Phase 2 | |
Recruiting |
NCT01747278 -
Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT02577393 -
Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy
|
Phase 2 | |
Withdrawn |
NCT01137591 -
Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
|
N/A |